Ilex, Pharma Forschung Kaufbeuen GmbH deal

ILXO will acquire 30 percent of Pharma Forschung, a CRO, for $1.7 million in cash and stock. ILXO has an option to purchase an additional 10 percent of the company in one year, and another 9 percent i...